Press release
Global Erythropoietin Stimulating Agent Market is Driven by Increasing Number of Patients Suffering from Anemia
Endogenous erythropoietin (EPO) is a glycoprotein hematopoietic hormone, which is synthesized, in the renal tubules. EPO helps in controlling and regulating the mechanism of erythropoiesisin the bone marrow. Due to anemia and renal problem, the production of erythropoietin (EPO) istroubled, resulting into fatigue, weakness, shortness of breath, pale skin and insomnia. For treating anemia,chemotherapy induced anemia, renal disorders and others erythropoietin stimulating drugs (EPO) are used.
Obtain Report Details @ http://www.transparencymarketresearch.com/erythropoietin-stimulating-agent-market.html
For development of synthetic form of erythropoietin drugs such as epoetin alfa, epoetin beta, darbepoetin alfa, epoetin delta, epoetin omega and others with the help of improved recombinant DNA technology. Recombinant erythropoietin is an artificialformof natural erythropoietin. These are made by cloning the gene for erythropoietin. Among synthetic EPO’sepoetin alfa, epoetin beta, epoetin omega, epoetin delta and darbepoetin-alpha are used extensively. Epoetin delta is another recombinant EPO that is been used for treating patients with chronic kidney disease (CKD).
GlobalErythropoietin stimulating agent market are driven by increasing number of patients suffering from anemia, anemia induced due to cancer, end stage renal disease (ESRD) and HIV treatment. In June 1989, Epoetin alfa was the first drug for EPO, manufactured by Amgen Inc. U.S FDA approved itunder the trade name “Epogen”. The global market for erythropoietin drugs are expected to grow in near future as increased cases of cancer and renal problem haveregistered.
Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8794
With the expiration of Amgen’s patent for Epogen, it has helped the production of other biosimilars EPO drugs. Hence, availability of many biosimilar drugs has renderedlow-cost option to the patients, therefore particularly, in the developing regions the adoption of EPO drugs have increased.
Based on product type erythropoietin stimulating agent can divided as Epoetin-alfa, Epoetin-beta, epoetin omega, epoetin delta and darbepoetin-alpha. Application of erythropoietin stimulating agents are classified as anemia, cancer chemotherapy, kidney disorders (ESRD and dialysis), antiretroviral treatment (ART) and others (neural disease and wound healing),
Some of the major players in erythropoietin stimulating agent market are Amgen Inc., Biocon, Celltrion, Inc., Hospira Inc., Intas Pharmaceuticals, Johnson & Johnson, Ranbaxy Laboratories Ltd., Roche, LG Life Sciences Ltd. and Teva Pharmaceutical Industries Ltd.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Erythropoietin Stimulating Agent Market is Driven by Increasing Number of Patients Suffering from Anemia here
News-ID: 529725 • Views: …
More Releases from Transparency Market Research
Global Spiritual and Wellness Products Market to Reach US$ 9.6 Billion by 2034, …
The global spiritual and wellness products market is witnessing unprecedented growth as consumers around the world increasingly prioritize mental, emotional, physical, and spiritual well-being. According to the latest industry analysis, the market, valued at US$ 4.2 billion in 2023, is projected to expand at a CAGR of 8.0% from 2024 to 2034, ultimately reaching US$ 9.6 billion by 2034. This surge underscores a dramatic shift toward wellness-focused lifestyles and scientific…
Global Outdoor Furniture Market to Reach USD 36.8 Billion by 2034, Driven by Ris …
The global Outdoor Furniture Market is poised for substantial expansion, projected to grow from US$ 19.5 billion in 2023 to US$ 36.8 billion by 2034, registering a CAGR of 6.0% during the forecast period. According to the latest industry assessment, rising consumer inclination toward outdoor living, rapid urbanization, and strong recovery in the hospitality and tourism industry continue to boost demand for stylish, weather-resistant, and durable outdoor furnishings.
As consumers increasingly…
Online Home Decor Market Set to Reach US$ 375.86 Billion by 2034, Driven by Digi …
The global online home decor market is undergoing a transformative shift, fueled by rapid urbanization, lifestyle enhancement trends, and the widespread adoption of digital commerce. As consumers increasingly prioritize aesthetics, functionality, and personalized living spaces, the online home decor industry is emerging as one of the fastest-growing segments in the global e-commerce landscape. According to the latest industry insights, the market, valued at US$ 188.27 billion in 2023, is projected…
Global Preventive Healthcare Technologies and Services Market Outlook 2034: Indu …
The global preventive healthcare technologies and services market has entered a transformative era, shaped by the increasing shift from curative to preventive care, rapid technological advancements, and growing consumer awareness. Valued at US$ 260.2 billion in 2023, the industry is forecast to expand at an impressive CAGR of 10.6% from 2024 to 2034, ultimately exceeding US$ 773.1 billion by 2034. This robust expansion is driven by innovations in early disease…
More Releases for EPO
Erythropoietin (EPO) Treatment Market Outlook and Future Projections for 2030
The erythropoietin (epo) treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Erythropoietin (EPO) Treatment Market, Global Outlook and Forecast 2025-2033
Summary: The Global Erythropoietin (EPO) Treatment Market was valued at US$9242 million in 2022 and is projected to reach US$ 19070 million by 2033, at a CAGR of 6.2% during the forecast period. The Global Erythropoietin (EPO) Treatment Market was valued at US$ 9.24 billion in 2022 and is expected to reach US$ 14.07 billion by 2029, growing at a 6.2% CAGR. EPO is primarily used to treat anemia caused…
Erythropoietin (EPO) Market Analysis & Growth Insights 2024-2033
The Business Research Company recently released a comprehensive report on the Global Erythropoietin (EPO) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
EPO Biomarkers Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global EPO Biomarkers Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Erythropoietin (EPO) Drugs Market: An Overview
Introduction:
Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing the…
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023
According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,…
